Inhibition of Hypertrophy Is a Good Therapeutic Strategy in Ventricular Pressure Overload-Reference-Cited by-同舟云学术

Inhibition of Hypertrophy Is a Good Therapeutic Strategy in Ventricular Pressure Overload

Published:2015-04-21 Issue:16 Volume:131 Page:1435-1447
ISSN:0009-7322
Container-title:Circulation
language:en
Short-container-title:Circulation

Author:

Schiattarella Gabriele G.¹,Hill Joseph A.¹

Affiliation:

1. From Departments of Internal Medicine (Cardiology) (G.G.S., J.A.H.) and Molecular Biology (J.A.H.), University of Texas Southwestern Medical Center, Dallas, TX.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Link

https://www.ahajournals.org/doi/pdf/10.1161/CIRCULATIONAHA.115.013894

Reference138 articles.

1. Cardiac Plasticity

2. Pathological Ventricular Remodeling

3. Hypertrophy of the Heart

4. Prognostic Implications of Echocardiographically Determined Left Ventricular Mass in the Framingham Heart Study

Cited by 193 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An Increase in the Ratio of Brain Natriuretic Peptide to Peak Transvalvular Pressure Gradient Suggests Coexistence of Cardiovascular Complications in Elderly Aortic Stenosis Patients;International Heart Journal;2024-07-31

2. Deletion of Setd7 protects against cardiac hypertrophy via inhibiting lipid oxidation;2024-07-30

3. Inhalable cardiac targeting peptide modified nanomedicine prevents pressure overload heart failure in male mice;Nature Communications;2024-07-18

4. Beneficial Effects of Exercise on Hypertension-Induced Cardiac Hypertrophy in Adolescents and Young Adults;Current Hypertension Reports;2024-06-18

5. Stromal Cell-SLIT3/Cardiomyocyte-ROBO1 Axis Regulates Pressure Overload-Induced Cardiac Hypertrophy;Circulation Research;2024-03-29